Samorita Hospital Limited (DSE:SAMORITA)
Bangladesh · Delayed Price · Currency is BDT 91.20
-2.70 (-2.88%)
At close: Sep 24, 2026
Samorita Hospital Ratios and Metrics
Market cap in millions BDT. Fiscal year is July - June.
Millions BDT. Fiscal year is Jul - Jun.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 23, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
| 1,988 | 1,232 | 1,546 | 1,478 | 1,387 | 1,268 | |
Market Cap Growth | 26.67% | -20.31% | 4.54% | 6.57% | 9.38% | 10.89% |
Enterprise Value | 1,944 | 1,197 | 1,506 | 1,466 | 1,356 | 1,212 |
Last Close Price | 91.20 | 56.09 | 69.74 | 66.71 | 62.16 | 56.14 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 23, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
PE Ratio | 185.31 | 91.04 | 126.70 | 2052.27 | 85.15 | 30.14 |
PS Ratio | 4.66 | 3.07 | 4.09 | 4.42 | 4.10 | 3.22 |
PB Ratio | 1.87 | 1.17 | 1.47 | 1.54 | 1.43 | 1.31 |
P/TBV Ratio | 1.87 | 1.17 | 1.47 | 1.54 | 1.43 | 1.31 |
P/FCF Ratio | 99.40 | 75.07 | 58.00 | - | - | - |
P/OCF Ratio | 43.14 | 32.88 | 34.78 | 55.78 | 39.65 | 21.12 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 23, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
EV/Sales Ratio | 4.56 | 2.98 | 3.98 | 4.39 | 4.01 | 3.08 |
EV/EBITDA Ratio | 44.93 | 29.27 | 36.54 | 54.66 | 30.64 | 17.36 |
EV/EBIT Ratio | 105.87 | 70.83 | 85.72 | 387.60 | 55.57 | 24.65 |
EV/FCF Ratio | 97.20 | 72.95 | 56.51 | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 23, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Debt / Equity Ratio | 0.00 | 0.00 | 0.02 | 0.04 | 0.06 | 0.06 |
Debt / EBITDA Ratio | 0.09 | 0.05 | 0.53 | 1.49 | 1.35 | 0.81 |
Debt / FCF Ratio | 0.20 | 0.12 | 0.85 | - | - | - |
Net Debt / Equity Ratio | -0.04 | -0.03 | -0.03 | 0.00 | -0.01 | -0.05 |
Net Debt / EBITDA Ratio | -1.04 | -0.89 | -0.73 | -0.08 | -0.20 | -0.73 |
Net Debt / FCF Ratio | -2.20 | -2.21 | -1.13 | 48.54 | 0.79 | 2.35 |
Asset Turnover | 0.35 | 0.33 | 0.33 | 0.30 | 0.30 | 0.37 |
Inventory Turnover | 8.39 | 9.00 | 8.00 | 7.10 | 7.25 | 8.64 |
Quick Ratio | 0.89 | 0.83 | 0.79 | 0.79 | 1.10 | 1.84 |
Current Ratio | 1.57 | 1.67 | 1.40 | 1.48 | 1.85 | 2.75 |
Return on Equity (ROE) | 1.01% | 1.28% | 1.21% | 0.07% | 1.68% | 4.43% |
Return on Assets (ROA) | 0.94% | 0.88% | 0.95% | 0.21% | 1.36% | 2.86% |
Return on Invested Capital (ROIC) | 0.91% | 1.24% | 1.28% | 0.09% | 1.74% | 4.26% |
Return on Capital Employed (ROCE) | 1.60% | 1.50% | 1.50% | 0.40% | 2.30% | 4.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 23, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 |
Earnings Yield | 0.54% | 1.10% | 0.79% | 0.05% | 1.17% | 3.32% |
FCF Yield | 1.01% | 1.33% | 1.72% | -0.00% | -0.81% | -1.70% |
Dividend Yield | 0.55% | 0.89% | 0.72% | - | 0.70% | 1.54% |
Payout Ratio | 101.60% | 80.56% | - | 1310.01% | 165.70% | - |
Total Shareholder Return | 0.55% | 0.89% | 0.72% | - | 0.70% | 1.54% |